CD34 and acute myeloid leukemia: These CD34+ leukemic cells are believed to be the main compartment for leukemic stem cells (LSCs) for most patients, a leukemic cell subset regarded to be important for chemoresistance and, ultimately, AML relapse [12,13,14].